Search alternatives:
point decrease » point increase (Expand Search)
026 decrease » _ decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
026 decrease » _ decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
2501
Brain uptake of [<sup>14</sup>C]docosahexaenoic acid (DHA) in 2-, 8-, 12-, and 24-month-old mice.
Published 2023Subjects: -
2502
The mRNA expression levels of Mfsd2a in brain microvessels from 2- and 24-month-old mice.
Published 2023Subjects: -
2503
MFSD2A expression levels in brain microvessels from 2-, 8-, 12-, and 24-month-old mice.
Published 2023Subjects: -
2504
-
2505
-
2506
-
2507
Cdk5 siRNA knockdown decreased Cdk5 activity, diminished WT1 expression and viable cell numbers, and increased cleaved caspase 3 level.
Published 2016“…After 72h incubation, cells were harvested and submitted to the Western blotting and kinase assay analysis. A&B. Western blots show that Cdk5 siRNA-transfected podocytes successfully decrease Cdk5 expression (upper panel, lane 2) and activity (3rd panel, lane 2 and bar 2, compared to the control siRNA cells, p<0.05), while the expression of cyclin I remain unchanged (2<sup>nd</sup> panel). …”
-
2508
-
2509
-
2510
-
2511
-
2512
-
2513
Long-Term Once-Daily Tiotropium Respimat® Is Well Tolerated and Maintains Efficacy over 52 Weeks in Patients with Symptomatic Asthma in Japan: A Randomised, Placebo-Controlled Stud...
Published 2015“…</p><p>Methods</p><p>285 patients with symptomatic asthma, despite treatment with ICS±LABA, were randomised 2:2:1 to once-daily tiotropium 5 μg, tiotropium 2.5 μg or placebo for 52 weeks (via the Respimat SoftMist inhaler) added on to ICS±LABA, in a double-blind, placebo-controlled, parallel-group study (NCT01340209). …”
-
2514
-
2515
Proteomic analysis of Δ<i>flrA</i> and Δ<i>flaA</i>.
Published 2023“…<p><b>(A) Adult mice competition assay of <i>V</i>. <i>cholerae</i> from mouse intestinal filtration.…”
-
2516
Systemic EP4 Antagonism Decreased Range of Motion and Increased Gliding Resistance after Flexor Tendon Repair.
Published 2015“…Antagonist treated repairs (black bars) had significant decreases in range of motion at 10 and 21 days post-repair, suggesting increasing adhesion formation in the earlier time points. …”
-
2517
Quantitation of seeding activity in brain tissue from a sporadic CJD patient using end-point RT-QUIC.
Published 2015“…<p>(a) BH (Pt 1) was diluted (5 × 10<sup>–5</sup> to 5 × 10<sup>–9</sup>) and subjected to RT-QUIC reaction containing human recPrP substrate. …”
-
2518
Decrease in ΔΨ on transition from the oxidized to the reduced state.
Published 2011“…<p>(A) Predicted dynamics of the transition induced by addition of 2 mM succinate to mitochondria initially in the oxidized state in the presence of 5 mM pyruvate, under the conditions of various proton leaks through the inner menbrane, slow leak, k<sub>lk</sub> = 17000, and fast leak, k<sub>lk</sub> = 80000 mL/(s·mg prot) (eq.H.1). …”
-
2519
-
2520